Treatment of Pyoderma Gangrenosum with Infliximab in Crohn's Disease

By Sapienza Mark S.   Cohen Sidney   Dimarino Anthony J.  

Digestive Diseases and Sciences, Vol. 49, Iss. 9, 2004-09 ,pp. : 1454-1457

Springer Publishing Company

Access to resources Recommend Favorite

Successful Treatment of Refractory Duodenal Crohn’s Disease with Infliximab

By Odashima Masaru   Otaka Michiro   Jin Mario   Horikawa Youhei   Matsuhashi Tamostu   Ohba Reina   Koizumi Shigeto   Kinoshita Nobukatsu   Takahashi Taiji   Watanabe Sumio  

Digestive Diseases and Sciences, Vol. 52, Iss. 1, 2007-01 ,pp. : 31-32

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab in the treatment of extra‐intestinal manifestations of Crohn's disease

By Rispo A.   Scarpa R.   Di Girolamo E.   Cozzolino A.   Lembo G.   Atteno M.   De Falco T.   Lo Presti M.   Castiglione F.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 5, 2005-10 ,pp. : 387-391

Informa Healthcare

Access to resources Recommend Favorite

Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma Gangrenosum

By Triantafillidis J. K.   Cheracakis P.   Sklavaina M.   Apostolopoulou K.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 7, 2002-07 ,pp. : 863-865

Informa Healthcare

Access to resources Recommend Favorite

Treatment-resistant lingual Crohn's disease disappears after infliximab

By Brunner Brigitte   Hirschi Claudia   Weimann Rosemarie   Seibold Frank  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 10, 2005-10 ,pp. : 1255-1259

Informa Healthcare

Access to resources Recommend Favorite